News & Media

Aplantex raises $ 1.3 m in initial round of financing

January 31, 2023

Montreal, January 31st, 2023/Businesswire – Mr. Patrick Charest, B. Sc., P. Eng., Aplantex’s CEO is pleased to announce that its initial round of financing was successfully completed. The company has managed to raise $ 1.3 M in start-up funds. This is a clear signal that its innovative and exclusive process and sound business model answer a clear market need. “The money will be used to ramp up the research laboratory, set up an initial production line, and to plan large-scale commercial production~ underlines Mr. Charest. “Aplantex is in full growth mode. Our team is committed to supplying companies having products that cater to the health, beauty, and nutrition needs of individuals with the essential molecules they require albeit at a lower cost than other production methods while also simplifying the supply chain and working within ESG parameters ~ concludes Mr. Charest.

For more information 


Other articles of interestView all

September 15, 2025

The Asian nutraceutical industry is a strong growth opportunity for Aplantex

To know more
August 21, 2025

Antimicrobial properties, a priority for Aplantex

To know more
August 14, 2025

A spotlight on 2 key team members

To know more